Company intelligence / Profile preview

Vingroup

Hanoi, Hanoi, Vietnam

Ownership: Private
Employees: ~51000
Development stage: Other

Overview

Vinbiocare, a Vingroup subsidiary, developed an mRNA COVID-19 vaccine in partnership with Arcturus Therapeutics. Factory built under GMP, expected to produce up to 200 million doses/year. Trials planned on 20,000+ subjects in Vietnam; seeking domestic emergency use approval

Therapeutic areas: Infectious Diseases
Modalities: mRNA-based drugsVaccine
Industry: Biotech

Partnerships

Arcturus Therapeutics

Beyond the preview

Go deeper on Vingroup.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vingroup.

Explore the full profile